Metraipolis › archive › dc_6d4e8b6cb666
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML — Europe PMC PMID:40706052
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40706052
- DOI
- 10.1182/bloodadvances.2025016399
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T06:45:35.535Z
- SHA-256 of the archived text
d0037da60d76cb070734b02e465a14e2b3ef16fb4868eb8c3c659911c8fa8cee- Stable URL of this page
https://metraipolis.com/documento/dc_6d4e8b6cb666
How to cite
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML — Europe PMC PMID:40706052 — Europe PMC (en), https://europepmc.org/article/MED/40706052 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6d4e8b6cb666 (Metraipolis archive dc_6d4e8b6cb666, sha256 d0037da60d76cb070734b02e465a14e2b3ef16fb4868eb8c3c659911c8fa8cee)
BibTeX
@misc{dc6d4e8b6cb666,
title = {Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML — Europe PMC PMID:40706052},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40706052},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6d4e8b6cb666; sha256 d0037da60d76cb070734b02e465a14e2b3ef16fb4868eb8c3c659911c8fa8cee},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40706052. Agents can read the archived copy with the MCP tool read_document.